INNOVIRO Trademark

Trademark Overview


On Tuesday, October 24, 2017, a trademark application was filed for INNOVIRO with the United States Patent and Trademark Office. The USPTO has given the INNOVIRO trademark a serial number of 87657840. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 25, 2019. This trademark is owned by Pfizer Inc.. The INNOVIRO trademark is filed in the Chemical Products category with the following description:

Active chemical ingredients for use in the manufacture of pharmaceuticals for hormone replacement therapy and for treating diseases and disorders related to: the autoimmune system, cardiovascular system, central nervous system, endocrine system, gastrointestinal system, metabolic system, musculoskeletal system, neurological system, neuromuscular system, respiratory system, urogenital system, genetics, immunology, infections, inflammation, menopause, ophthalmology, psychiatry, urology, viruses, blood, liver, erectile dysfunction, sexual dysfunction, cancer, pain, diabetes, fungus, and dermatology
innoviro

General Information


Serial Number87657840
Word MarkINNOVIRO
Filing DateTuesday, October 24, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 25, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 29, 2018

Trademark Statements


Goods and ServicesActive chemical ingredients for use in the manufacture of pharmaceuticals for hormone replacement therapy and for treating diseases and disorders related to: the autoimmune system, cardiovascular system, central nervous system, endocrine system, gastrointestinal system, metabolic system, musculoskeletal system, neurological system, neuromuscular system, respiratory system, urogenital system, genetics, immunology, infections, inflammation, menopause, ophthalmology, psychiatry, urology, viruses, blood, liver, erectile dysfunction, sexual dysfunction, cancer, pain, diabetes, fungus, and dermatology

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, November 2, 2017
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, February 25, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 25, 2019ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 24, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 29, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 29, 2018PUBLISHED FOR OPPOSITION
Wednesday, May 9, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 23, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 19, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 18, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 18, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 9, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 9, 2018NON-FINAL ACTION E-MAILED
Friday, February 9, 2018NON-FINAL ACTION WRITTEN
Friday, February 2, 2018ASSIGNED TO EXAMINER
Thursday, November 2, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, October 27, 2017NEW APPLICATION ENTERED IN TRAM